Jasmina I. Radeva - Concepedia

Author

Jasmina I. Radeva

Clinical Research Institute

Also Known As

J I Radeva, J Radeva, J.I Radeva, J.I. Radeva, JASMINA I. RADEVA, Jasmina I Radeva, Jasmina I. Radeva, Jasmina Radeva

Publications

387

Citations

H-Index

Concepts

All Affiliations

Clinical Research Institute Duke Medical Center Duke University Ortho Clinical Diagnostics (United States)Duke University Hospital

About

Jasmina I. Radeva is an author at Clinical Research Institute specializing in medicine, health sciences, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	84
2	Health Sciences	3	3	47
3	Public Health	3	3	54
4	Health Policy	3	3	54
5	Emergency Medicine	2	2	40

Jasmina I. Radeva

Publications

376

Citations

H-Index

Page 1

	Year	Citations
Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind? David S. Bach, Jasmina I. Radeva, Howard G. Birnbaum, PubMed	2007	106
Geographic Variation in the Prescription of Schedule II Opioid Analgesics among Outpatients in the United States Lesley H. Curtis, Jennifer Stoddard, Jasmina I. Radeva, Health Services Research	2006	88
COST-EFFECTIVENESS OF ZOLEDRONIC ACID FOR THE PREVENTION OF SKELETAL COMPLICATIONS IN PATIENTS WITH PROSTATE CANCER Shelby D. Reed, Jasmina I. Radeva, G. Alastair Glendenning, The Journal of Urology	2004	60
Resource use, costs, and quality of life among patients in the multinational Valsartan in Acute Myocardial Infarction Trial (VALIANT) Shelby D. Reed, Jasmina I. Radeva, Kevin P. Weinfurt, American Heart Journal Percutaneous Coronary InterventionMultinational ValsartanHealthcare ValueCardiovascular DiseaseHealth Policy	2005	24
Economic Evaluation of Zoledronic Acid Versus Pamidronate for the Prevention of Skeletal-Related Events in Metastatic Breast Cancer and Multiple Myeloma Shelby D. Reed, Jasmina I. Radeva, G. Alastair Glendenning, American Journal of Clinical Oncology Breast OncologyCancer ManagementOsteoporosisOrthopaedic SurgeryBone Disease	2005	20
State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction Manesh R. Patel, Trip J. Meine, Jasmina I. Radeva, Journal of the American College of Cardiology Health PolicyCardiovascular DiseaseClinical SpecialtiesContinuing Medical EducationPatient Education	2004	16
Correction to “Geographic Variation in the Prescription of Schedule II Opioid Analgesics among Outpatients in the United States” Lesley H. Curtis, Jennifer Stoddard, Jasmina I. Radeva, Health Services Research Opioid EpidemicHealth PolicyPain MedicineDrug PolicyHealth Services Research	2006	14
Economic Evaluation of Weekly Epoetin Alfa versus Biweekly Darbepoetin Alfa for Chemotherapy-Induced Anaemia Shelby D. Reed, Jasmina I. Radeva, Davey B. Daniel, PharmacoEconomics Health EconomicsMedicineMetronomic TherapyHematologyPharmacology	2006	13
Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia Shelby D. Reed, Jasmina I. Radeva, Davey B. Daniel, Current Medical Research and Opinion	2005	13
National estimates of the use of hematopoietic stem-cell transplantation in children with cancer in the United States Jasmina I. Radeva, E VanScoyoc, Franklin O. Smith, Bone Marrow Transplantation OncologyMarrow TransplantationTransplantationPediatric HematologyStem Cell Transplantation	2005	11

Page 1